Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000006

CEO bought 120,500 shares at an average $0.03 ($3,306)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

22 lines
Date Transaction Shares Price Value Owned after D/I
2019-01-22 Purchase : show line 1 in the form +5,000 $0.03 $134 20,878,123 D
2019-01-22 Purchase : show line 2 in the form +5,000 $0.03 $134 20,883,123 D
2019-01-22 Purchase : show line 3 in the form +10,000 $0.03 $267 20,893,123 D
2019-01-22 Purchase : show line 4 in the form +5,000 $0.03 $135 20,898,123 D
2019-01-22 Purchase : show line 5 in the form +5,000 $0.03 $130 20,903,123 D
2019-01-22 Purchase : show line 6 in the form +5,000 $0.03 $130 20,908,123 D
2019-01-22 Purchase : show line 7 in the form +5,000 $0.03 $130 20,913,123 D
2019-01-22 Purchase : show line 8 in the form +10,000 $0.03 $260 20,923,123 D
Open-market purchases · 120,500 sh · avg $0.03 · $3,306
Loading xslF345X03/primary_doc.xml…